Table 3 Characteristics of the 552 propensity score-matched cases.
From: Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
Variables | DOAC group | Clopidogrel group | SMD |
|---|---|---|---|
Patient, n = 124 | Patient, n = 145 | ||
Polyp, n = 276 | Polyp, n = 276 | ||
Age, year, mean ± SD | 72.5 ± 8.6 | 72.3 ± 8.5 | 0.021 |
Sex | 0.017 | ||
Male | 208 | 210 | |
Female | 68 | 66 | |
Comorbidities | |||
Respiratory disease | 19 | 19 | 0.000 |
Diabetes mellitus | 91 | 93 | 0.015 |
Hypertension | 159 | 151 | − 0.058 |
Cardiovascular disease | 73 | 72 | − 0.008 |
Polypectomy technique | 0.017 | ||
Cold snare polypectomy | 67 | 69 | 0.801 |
Others | 209 | 207 | |
Polyp size, mm, mean ± SD | 7.44 ± 3.87 | 7.74 ± 4.48 | − 0.072 |
Location | 0.030 | ||
Right colon | 169 | 165 | |
Left colon | 107 | 111 | |
Histopathology | − 0.040 | ||
Adenoma | 209 | 201 | |
Others | 67 | 75 | |
Compliance with antithrombotic discontinuation guideline | 241 | 243 | − 0.022 |
Prophylactic clipping | 85 | 83 | − 0.016 |
